Page last updated: 2024-11-07

etiocholanolone and Experimental Mammary Neoplasms

etiocholanolone has been researched along with Experimental Mammary Neoplasms in 2 studies

Etiocholanolone: The 5-beta-reduced isomer of ANDROSTERONE. Etiocholanolone is a major metabolite of TESTOSTERONE and ANDROSTENEDIONE in many mammalian species including humans. It is excreted in the URINE.
3alpha-hydroxy-5beta-androstan-17-one : An androstanoid that is 5beta-androstane substituted by an alpha-hydroxy group at position 3 and an oxo group at position 17. It is a metabolite of testosterone in mammals.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abul-Hajj, YJ1
Forrest, AP1

Reviews

1 review available for etiocholanolone and Experimental Mammary Neoplasms

ArticleYear
Hormones and neoplasia.
    Journal of clinical pathology. Supplement (Royal College of Pathologists), 1974, Volume: 7

    Topics: Adrenalectomy; Animals; Breast Neoplasms; Calcium; Castration; Cell Transformation, Neoplastic; Diet

1974

Other Studies

1 other study available for etiocholanolone and Experimental Mammary Neoplasms

ArticleYear
Steroid delta 4-5 beta-reductase in human mammary tumors.
    Steroids, 1979, Volume: 33, Issue:1

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; B

1979